Darmstadt: An Overview - Merck makes an investment in a fresh facility dedicated to overseeing product quality.
The pharmaceutical and specialty chemicals company Merck is pouring 62 million euros into its headquarters in Darmstadt to enhance the quality control of its Life Science division. The nearly 10,000 square meter facility is set to house around 135 employees from various departments and is scheduled to be completed by mid-2025, according to Merck's announcement on Tuesday. This extensive renovation will enable better testing of products for purity, ensuring any undesirable substances are removed. Merck's Life Science division includes items for pharmaceutical research, and this newly constructed building is part of a larger investment plan for the Darmstadt location, which costs 1.5 billion euros by 2025.
"The new building dedicated to quality control reaffirms our dedication to delivering top-notch, safe products to our customers and their patients," stated Robert Nass, a manager at Merck Life Science.
